Kadir Joins Mirada Medical

Mirada Medical (Oxford, UK) announces the appointment of Dr Timor Kadir as Chief Science and Technology Officer. Kadir brings with him a decade of experience in the research and development of clinical applications which combine information from multiple sources and imaging modalities. Mirada’s Chief Executive, Hugh Bettesworth said, “I am delighted to welcome Dr Kadir. Mirada believes that innovation and experience must be combined to solve the most important clinical problems. Dr Kadir has a proven track record in leading the technological development of today’s foremost imaging software solutions.” Kadir obtained his PhD from Oxford University’s renowned medical vision lab under the supervision of Mirada’s founder and current director Professor Sir Michael Brady. Kadir’s  most recent work was in the development of leading edge PET/CT oncology applications for distribution with the latest high definition PET/CT scanners.